Looking to publish in Neuro-Oncology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginNeuro-Oncology is a medical oncology and neurology journal published on behalf of the Society for Neuro-Oncology. It reports a 2024 Impact Factor of 13.4 and a 2024 CiteScore of 30.2, and offers publication under either a standard licence or an open access licence.
Looking to publish in Neuro-Oncology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Neuro-Oncology accepts the following article types. Click on an article type to view submission instructions.
Reviews
Basic And Translational Investigations
Clinical Investigations
Meta-Analyses
Systematic Reviews
Letters To The Editor
Guidelines
Recent Publications
EGFRvIII overexpression and loss of mouse-specific CDKN2A in glial cells leads to spontaneous gliomagenesis in a novel mouse model
Olivia Singh, Yosef Ellenbogen, Mathew Voisin, Mira Li, Hafsah Ali, Qingxia Wei, Vikas Patil, Jeff Liu, Shirin Karimi, Mark Wilson, Sameer Agnihotri, Kenneth Aldape, Andrew Gao, Gelareh Zadeh
Early versus late venous thromboembolism in patients with newly diagnosed high-grade gliomas
Jasmin Jo, Ruyun Jin, Emily Kopp, Nicole Ng, Adarsh Menon, Gabrielle Li, Hong Zhu, David Schiff
EGFRvIII-Positive Glioblastoma: Structural Rewiring, Immune Microenvironmental Remodeling, and Therapeutic Resistance
Haoyuan Ye, Jinming Qiu, Fangge Zhu, Rong Quan, Wenting Su, Renxi Wang, Yi Fu
Firmonertinib 160mg in EGFR-Mutated NSCLC with Brain Metastases After EGFR-TKI Resistance (iFORCE): Clinical Outcomes and Mechanistic Insights
Mengxing You, Tongji Xie, Lige Wu, Jiayu Liu, Yan Li, Qi Wang, Jie Zhang, Zihe Wang, Ran Gao, Xuezhi Hao, Junling Li, Puyuan Xing
MRI-Based Machine Learning to Differentiate True Progression from Pseudoprogression in Glioblastoma: An Updated Systematic Review and Meta-Analysis
Xin Zhang, Xiaopeng Guo, Yu Wang, Konrad Wagstyl, Thomas C Booth
Frequently asked questions
How long does it take to publish?
Papers are normally reviewed within 3-4 weeks of submission. Appeals must be submitted within 4 weeks of the decision. Authors have 3 weeks to accept or decline a transfer offer to a sister journal. Page proof corrections must be returned within 2 working days. Advance Access articles are published online soon after acceptance.
Reformat to Neuro-Oncology using Livewrite PremiumIs a cover letter required?
A cover letter addressed to the editor is required as a separate Word file. It should declare whether the manuscript or any part of it has been previously published or submitted elsewhere, whether all co-authors have read and approved the submission, and agreement to pay approximately $600 per color figure if color figures are submitted. A new cover letter is required for revised manuscripts.
Reformat to Neuro-Oncology using Livewrite PremiumWhat are the publication costs?
The journal operates a hybrid model. Standard licence publication has no licence charge, open access publication requires an APC, and certain non-open access article types incur a flat publication fee of $800 for EANO, SNO, or ASNO society members or $1000 for non-society members.
Reformat to Neuro-Oncology using Livewrite Premium